Relapsed Non Hodgkin Lymphoma Not Yet Recruiting Phase 2 Trials for Anakinra (DB00026)

IndicationStatusPhase
DBCOND0062858 (Relapsed Non Hodgkin Lymphoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04150913Anakinra In Car-T Cell Mediated NeurotoxicityTreatment